Recombinant batroxobinAlternative Names: rBAT
Latest Information Update: 26 Jan 2011
At a glance
- Originator Sinobiomed
- Class Coagulants; Crotalid venoms; Recombinant proteins; Serine endopeptidases
- Mechanism of Action Fibrinogen inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Haemorrhage; Surgical blood loss